Sagimet Biosciences Inc (NASDAQ:SGMT) shares traded -6.40% lower at $3.95 on Wall Street last session.
SGMT stock price is now -14.41% away from the 50-day moving average and -35.59% away from the 200-day moving average. The market capitalization of the company currently stands at $126.04M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $32, H.C. Wainwright recently initiated with Buy rating for Sagimet Biosciences Inc (NASDAQ: SGMT). On March 25, 2024, Leerink Partners recently initiated its ‘Outperform’ rating on the stock quoting a target price of $26, while ‘TD Cowen’ rates the stock as ‘Outperform’
In other news, Happel David, President & CEO bought 12,100 shares of the company’s stock on Mar 26 ’24. The stock was bought for $63,731 at an average price of $5.27. Upon completion of the transaction, the President & CEO now directly owns 639,200 shares in the company, valued at $2.52 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 07 ’23, President & CEO Happel David bought 1,600 shares of the business’s stock. A total of $6,560 was incurred on buying the stock at an average price of $4.10. This leaves the insider owning 627,100 shares of the company worth $2.48 million. A total of 34.85% of the company’s stock is owned by insiders.
During the past 12 months, Sagimet Biosciences Inc has had a low of $2.13 and a high of $20.71. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 43.12, and a quick ratio of 43.12. The fifty day moving average price for SGMT is $4.5864 and a two-hundred day moving average price translates $6.091875 for the stock.
The latest earnings results from Sagimet Biosciences Inc (NASDAQ: SGMT) was released for 2024-03-31. The net profit margin was -1395.90% and return on equity was -26.35% for SGMT.
